Conclusion
This article highlights cystic fibrosis patients are at risk of drug-drug interactions with cardiovascular medications. Therefore, this article emphasises the need for physicians to consider cardiovascular drug-drug interactions when planning the therapeutic regimen for CF exacerbation.